These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10665107)

  • 1. Precipitated withdrawal in an opioid-dependent outpatient receiving alternate-day buprenorphine dosing.
    Jacobs EA; Bickel WK
    Addiction; 1999 Jan; 94(1):140-1. PubMed ID: 10665107
    [No Abstract]   [Full Text] [Related]  

  • 2. Severe opiate withdrawal in a heroin user precipitated by a massive buprenorphine dose.
    Clark NC; Lintzeris N; Muhleisen PJ
    Med J Aust; 2002 Feb; 176(4):166-7. PubMed ID: 11913917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complications arising from intravenous buprenorphine abuse.
    Seet RC; Oh VM; Lim EC
    QJM; 2007 May; 100(5):312-3. PubMed ID: 17456611
    [No Abstract]   [Full Text] [Related]  

  • 4. Emergency management of inadvertent accelerated opiate withdrawal in dependent opiate users.
    Lubman D; Koutsogiannis Z; Kronborg I
    Drug Alcohol Rev; 2003 Dec; 22(4):433-6. PubMed ID: 14660133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The place of detoxification in treatment of opioid dependence.
    Gowing LR; Ali RL
    Curr Opin Psychiatry; 2006 May; 19(3):266-70. PubMed ID: 16612211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation on drug dependence of buprenorphine.
    Liu ZM; Lü XX; Lian Z; Mu Y; Guo P; An X
    Acta Pharmacol Sin; 2003 May; 24(5):448-52. PubMed ID: 12740181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Buprenorphine tablet versus liquid: a clinical trial comparing plasma levels, efficacy, and symptoms.
    Chawarski MC; Moody DE; Pakes J; O'Connor PG; Schottenfeld RS
    J Subst Abuse Treat; 2005 Dec; 29(4):307-12. PubMed ID: 16311183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial.
    Marsch LA; Bickel WK; Badger GJ; Stothart ME; Quesnel KJ; Stanger C; Brooklyn J
    Arch Gen Psychiatry; 2005 Oct; 62(10):1157-64. PubMed ID: 16203961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nalmefene Mistakenly Prescribed to Reduce Alcohol Consumption in Patients Under Buprenorphine Substitution Therapy Resulting in Acute Opioid Withdrawal: Management in an Emergency Setting.
    Pélissier F; Rougé Bugat ME; Nubukpo P; Franchitto N
    J Clin Psychopharmacol; 2016 Feb; 36(1):100-3. PubMed ID: 26658085
    [No Abstract]   [Full Text] [Related]  

  • 10. Low efficacy of non-opioid drugs in opioid withdrawal symptoms.
    Hermann D; Klages E; Welzel H; Mann K; Croissant B
    Addict Biol; 2005 Jun; 10(2):165-9. PubMed ID: 16191669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychotic symptoms following buprenorphine withdrawal.
    Karila L; Berlin I; Benyamina A; Reynaud M
    Am J Psychiatry; 2008 Mar; 165(3):400-1. PubMed ID: 18316438
    [No Abstract]   [Full Text] [Related]  

  • 12. Using buprenorphine to facilitate entry into residential therapeutic community rehabilitation.
    Collins ED; Horton T; Reinke K; Amass L; Nunes EV
    J Subst Abuse Treat; 2007 Mar; 32(2):167-75. PubMed ID: 17306725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical efficacy and abuse potential of combination buprenorphine-naloxone in the treatment of opioid dependence.
    Mammen K; Bell J
    Expert Opin Pharmacother; 2009 Oct; 10(15):2537-44. PubMed ID: 19708849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managing opioid withdrawal precipitated by buprenorphine with buprenorphine.
    Oakley B; Wilson H; Hayes V; Lintzeris N
    Drug Alcohol Rev; 2021 May; 40(4):567-571. PubMed ID: 33480051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outpatient opioid addiction treatment using buprenorphine.
    Roberson CM
    Ala Nurse; 2010; 37(2):13-6; quiz 17. PubMed ID: 20666206
    [No Abstract]   [Full Text] [Related]  

  • 16. Drugs approved for opiate dependence.
    FDA Consum; 2003; 37(1):6. PubMed ID: 12625293
    [No Abstract]   [Full Text] [Related]  

  • 17. Buprenorphine: a safe agent for opioid dependent patients who are under the increased risk of stroke?
    Yulug B; Ozan E
    J Opioid Manag; 2009; 5(3):134. PubMed ID: 19662922
    [No Abstract]   [Full Text] [Related]  

  • 18. [New drugs for substitution treatment of opioid dependence. Buprenorphine and 1-alpha-acetylmethadol (LAAM) ].
    Petersen H; Skauge L; Svejsø J; Ege PP
    Ugeskr Laeger; 2000 Nov; 162(48):6553-6. PubMed ID: 11187226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Buprenorphine as a new alternative for detoxification of heroin addicts. It causes only mild withdrawal problems, abating quickly].
    Blennow G; Fergusson A; Medvedeo A
    Lakartidningen; 2000 Apr; 97(15):1830-3. PubMed ID: 10815411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Buprenorphine for depression: the un-adoptable orphan.
    Callaway E
    Biol Psychiatry; 1996 Jun; 39(12):989-90. PubMed ID: 8780832
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.